Ziprasidone
Quick Overview for Ziprasidone (ABIN4868107)
应用范围
-
-
原理
- Ziprasidone (marketed as Geodon, Zeldox) was the fifth atypical antipsychotic to gain FDA approval (February 2001). Ziprasidone is Food and Drug Administration (FDA) approved for the treatment of schizophrenia, and the intramuscular injection form of ziprasidone is approved for acute agitation in schizophrenic patients. Ziprasidone has also received approval for acute treatment of mania associated with bipolar disorder.
-
产品特性
-
Source of Compound: synthetic
Target: 5-HT Receptor antagonist,AChR antagonist,Adrenergic Receptor agonist ,Dopamine Receptor antagonist,Histamine antagonist
Receptor: 5-HT receptor,Muscarinic AChR,Adrenergic receptor,Dopamine receptor,Histamine H1 receptor
-
纯化方法
- All the products are sent with COA, HPLC and NMR inspection report to guarantee the quality.
-
纯度
- 99 %
-
Formula
- C21H21ClN4OS•HCl
-
Solubility
- In water, 2.13 mg/L
-
-
-
-
应用备注
- Optimal working dilution should be determined by the investigator.
-
限制
- 仅限研究用
-
-
-
状态
- Solid
-
储存条件
- -20 °C
-
储存方法
-
For the majority of compounds, they could be dissolved in DMSO or other organic solvent.
Their stock solution can be stored at -20°C for up to 3 months and aliquoted for sampling convenience.
Several freeze/thaw cycles should not damage the activity of our small molecule products.
However, in many instances the aqueous solutions of some compounds need to be made fresh and cannot be stored. For these compounds, their solution should be prepared just before use and stored no longer than 24 hours. -
有效期
- 24 months
-
-
-
背景
- Neuroscience
-
分子量
- 412.94 g/mol
-
CAS-编号
- 146939-27-7
-
-